FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Allergy topics
Autoimmune
Prophylactic
Ophthalmic
Autoimmune Disorder
Immune Disorder
Dermatitis
Staurosporin
Aspergillosis
Angioedema
Allergic Rhinitis
Food Allergy
Therapeutical
Bronchopulmonary
Staurosporine
Sudden Infant Death

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Allergy patents



      
           
This page is updated frequently with new Allergy-related patent applications. Subscribe to the Allergy RSS feed to automatically get the update: related Allergy RSS feeds. RSS updates for this page: Allergy RSS RSS


Date/App# patent app List of recent Allergy-related patents
01/29/15
20150031706
 Novel compound useful for the treatment of degenerative and inflammatory diseases patent thumbnailnew patent Novel compound useful for the treatment of degenerative and inflammatory diseases
A pyrazolopyridine compound according to formula i, able to inhibit jak is disclosed, as well as pharmaceutically acceptable salts, a solvate thereof, solvates of the pharmaceutically acceptable salts and biologically active metabolites thereof. The compound may be prepared as a pharmaceutical composition, and may be used for the treatment or prophylaxis of a variety of conditions in mammals including humans, and particularly, such conditions as may be associated with aberrant jak activity, including by way of non-limiting example, allergy, inflammatory conditions, autoimmune diseases, proliferative diseases, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of il6..
01/29/15
20150026892
 Humidity and allergy control device patent thumbnailnew patent Humidity and allergy control device
A temporary artificial environment for maintaining an increased level of humidity is created over a sleeping person by suspending a perforated netting or perforated net-type material over a supporting framework creating a restricted air volume environmental or enclosed space over said sleeping person as said person respires to retard the evaporation of moisture within the said enclosed space and thereby the unwanted drying of nasopharyngeal tissues of the sleeping person by the ambient environment, thereby increasing the healthfulness of the nasal pharyngeal membranes of the sleeping person.. .
01/22/15
20150025412
 Allergy testing system, method and kit patent thumbnailAllergy testing system, method and kit
An allergy skin test kit includes a template having puncture site indicators and a computer-readable storage medium storing allergy test information that associates the puncture site indicators of the template with template locations or test substance indicators. A method of performing an allergy skin test includes providing a template having puncture site indicators.
01/22/15
20150025034
 Composition for care and hygiene of the auditory canal patent thumbnailComposition for care and hygiene of the auditory canal
The aim of the invention is to propose a composition for the care and hygiene of the auditory canal, in particular a cerumenolytic composition, which is effective for dissolving and preventing the appearance of plugs of cerumen, which is free from products irritating to the auditory canal or a source of allergy, such as preservatives or surfactants of animal origin, which is biodegradable and non-toxic for the environment, which can be used under non-sterile conditions while ensuring satisfactory preservation and stability and which does not require rinsing after use thereof. To this end, the invention concerns a composition for the care and hygiene of the auditory canal that is characterised in that it comprises a pair of surfactants consisting of an n-acyl sarcosinate sodium salt having an hlb greater than or equal to 25 and a sucrose fatty acid ester having an hlb greater than or equal to 11..
Laboratoires Gilbert
01/15/15
20150017143
 Composition comprising specific lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms patent thumbnailComposition comprising specific lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
A composition comprising specific lactobacillus helveticus strains is provided for reducing the symptoms of allergies originating from food, respiratory or contact allergens. Preferably the composition reduces symptoms of allergies (secondary prevention) while also able to reduce sensitization (primary prevention)..
Nestec S.a.
01/08/15
20150011802
 Partially halogenated, hydroxylated fullerene and allergen adsorbent using the same patent thumbnailPartially halogenated, hydroxylated fullerene and allergen adsorbent using the same
Provided are a novel fullerene derivative which can adsorb quickly and efficiently an allergen which may cause a pollen allergy without releasing the allergen again, does not contain a metal or the like which may cause a harmful effect to a human body, and is easily applicable, impregnable, or chemically bondable onto surface of various materials: and a process for producing the same. The fullerene derivative is characterized in that a halogen group and many hydroxyl groups are bonded directly to a fullerene nucleus.
Totai Co., Ltd.
12/25/14
20140378456
 Benzimidazole derivatives as pi3 kinase inhibitors patent thumbnailBenzimidazole derivatives as pi3 kinase inhibitors
This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kα, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries.
Glaxosmithkline Llc
12/25/14
20140377311
 Method of preventing allergies patent thumbnailMethod of preventing allergies
The present invention relates to compositions and methods for preventing allergy in a subject. Particularly, the present invention relates to epicutaneous prevention of allergies in children.
Dbv Technologies
12/18/14
20140371445
 Quinic acid derivative, process for preparation and uses thereof patent thumbnailQuinic acid derivative, process for preparation and uses thereof
The present invention relates to a quinic acid derivative, preparation process of the same and pharmaceutical uses thereof. The quinic acid derivative has a quinic acid-like structure which binds to cd28, blocks t-cell signal 2 pathway via cd28, and suppresses t-cell activation.
National Applied Research Laboratories
12/11/14
20140364607
 Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor patent thumbnailBenzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by h4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.. .
12/11/14
20140363818

Egfr and par2 regulation of intestinal permeability


The present invention provides methods for diagnosing an immune-mediated disease, e.g., an autoimmune disease, an allergy or an inflammatory disease. Diagnosis is made by detecting a heterozygous or homozygous genotype of haptoglobin 2 or by detecting and quantifying pre-haptoglobin 2 mrna or protein.
12/11/14
20140363470

Pharmaceutical formulations and the use thereof for the treatment of peanut allergy


The present invention relates to compositions which can be used in immunotherapy and especially to compositions which can be used in immunotherapy for mammals, such as human mammals, suffering from peanut allergy. The present invention further relates to the use of the present compositions for the therapeutic treatment for desentizing the immune system of a mammal suffering from an allergy by immunotherapy and the use of the present compositions in a prophylactic treatment of a mammal with high predisposition to develop a certain allergy.
12/04/14
20140357695

Rnai-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions


Rna interference is provided for inhibition of spleen tyrosine kinase (syk) mrna expression, in particular, for treating patients having a syk-related inflammatory condition or at risk of developing a syk-related inflammatory condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, allergy, or mast-cell disease.. .
12/04/14
20140357614

Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine h4 receptor


Diamino-pyridine, pyrimidine and pyridazine compounds which may be used as h4 receptor modulators, and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by h4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.. .
12/04/14
20140356372

Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor


The present invention provides methods for treating, preventing or reducing the severity of allergic reactions. The present invention also provides methods for enhancing the efficacy and/or safety of an allergen-specific immunotherapy (sit) regimen.
11/27/14
20140350052

Methods and compositions for reducing serum levels of immunoglobulin e (ige)


The present disclosure provides methods and pharmaceutical compositions for reducing the serum level of immunoglobulin ige in an animal or human subject. It has been found that reducing or inhibiting the activity of the cannabinoid receptor cb2 leads to an increase in ige in serum levels.
11/27/14
20140349311

Therapeutic agent for autoimmune diseases or allergy, and screening for the therapeutic agent


Disclosed is a therapeutic agent for treating a cellular immune disease, comprising as an active ingredient a substance that inhibits binding between sema3a and a neuropilin-1/plexin-a1 heteroreceptor. The substance includes, for example, a sema3a neutralizing antibody, a neuropilin-1 neutralizing antibody, or a soluble neuropilin-1 or derivative thereof.
11/27/14
20140348935

Treatment of food intolerance and food allergy with iga


A process is provided for inhibiting symptoms of food allergy or food intolerance in a subject that includes the oral adminstration to the subject suffering from food allergy or food intolerance an igm. When administered in a therapeutic quantity based on the subject characteristics and the type of igm, symptoms of food allergy or food intolerance in that subject are inhibited.
10/30/14
20140323480

Imidazopyridine derivatives as pi3 kinase


This invention relates to the use of imidizopyridine derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kα, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of imidizopyridines in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries.
10/30/14
20140322257

Fusion proteins representing different ns: proposal for a vaccine against allergy to mites


The present invention refers to recombinant dna molecules codifying fused peptides from different allergens from blomia tropicalis and dermatophagoides pteronyssinus having potential usefulness in prevention and treatment of allergies caused by domestic mites. Specifically, the invention discloses fusion proteins composed by different fragments of allergens der p 1, der p 2, der p 7, der p 8, blo t 5, blo t 8, blo t 18, blo t 12 and blo t 13 with reduced serum ige reactivity in allergic and non allergic individuals.
10/23/14
20140316772

Verification of extracted data


Facts are extracted from speech and recorded in a document using codings. Each coding represents an extracted fact and includes a code and a datum.
10/23/14
20140315888

Novel heterocyclic derivatives and their uses


The present invention relates to novel heterocyclic compounds useful in preparing drugs for treatment of diseases associated with various functions of the histamine 4 receptor. Especially, the said drugs are useful for treatment of inflammatory diseases, allergy, pain, nasal polyps, rhinitis, chronic sinusitis, nasal congestion, nasal itch, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria, idiopathic chronic urticaria, scleroderma, conjunctivitis, keratoconjunctivitis, ocular inflammation, dry eye, cardiac dysfunction, arrhythmia, atherosclerosis, multiple sclerosis, inflammatory bowel disease (including colitis, crohn's disease, ulcerative colitis), inflammatory pain, neuropathic pain, osteoarthritic pain, autoimmune thyroid disease, immune-mediated (also known as type i) diabetes, lupus, post-operative adhesions, vestibular disorders and cancer..
10/23/14
20140314800

Beta-lactoglobulin peptides for treating cow's milk protein allergy


The present invention relates to a nutritional, preferably enteral, composition for use in the treatment of cow's milk allergy in infants allergic to cow's milk containing specific beta-lactoglobulin peptides, which are able to reduce, in particular abolish the acute symptoms of cow's milk protein allergy.. .
10/09/14
20140303089

Plant hsp70 for use in the treatment of food allergy


Object of the invention is to provide a treatment for food allergy, in particular for peanut or milk allergy. This object was met by providing a plant hsp70 or a hydrolysate thereof for use in the prophylactic or therapeutic treatment of a food allergy..
10/09/14
20140302153

Methods and treatment for allergies and inflammation associated with gastrointestinal diseases


Methods of the prophylaxis of the development of allergy in a patient at risk of sensitization to an antigen(s) or allergen(s) due to impaired gastrointestinal functions include administering a mast cell inhibitor, e.g., ketotifen, e.g., ketotifen fumarate. Methods for prophylactically treating, reducing, delaying or controlling gastrointestinal disorders include administering a mast cell stabilizer, e.g., ketotifen to a patient in need thereof.
10/09/14
20140302071

Peptides for vaccine


The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.. .
10/09/14
20140302045

Igy composition for use in celiac disease


The present invention relates to an igy composition characterized in that said igy composition contains igy antibodies, fragments, and/or fab fragments thereof that specifically bind to a peptide with the amino acid sequence of seq id no: 1 and to the use of this igy composition in the therapy of celiac disease, rheumatism, and/or wheat allergy.. .
10/02/14
20140296482

Method to screen for selective peptides that inhibit the biological activity of calcineurin


The invention relates to the biotechnology sector involving the area of human health. More specifically, the invention is based on the surprising usefulness of peptides lxvpc1, c3 and c4 as efficient selective inhibitors of the calcineurin signalling pathway (cn)-nfat and the phosphate activity of cn.
10/02/14
20140296224

Quinoline derivatives as pi3 kinase inhibitors


Invented is a method of inhibiting the activity/function of pi3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives..
09/18/14
20140276196

System and allergy testing


An allergy testing device is formed by a blister pack containing a series of collapsible chambers each associated with an allergen and a lancet. The allergy testing device may be placed adjacent to a patient's skin and actuated by applying pressure to the collapsible chambers to open the chambers and release the reagents contained therein.
09/18/14
20140274943

Medicinal cream made using silver sulphadiazine and chitosan and a process to make it


The present invention is directed to a composition for treating bacterial skin infections, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, and an antibacterial active ingredient.
09/18/14
20140267088

Touch panel pen thereof


A touch panel pen comprising: a pen is a conductive rod with a connector in front; a fixed stand is a conductive body located in connector of the pen, a through-hole is on the center of the fixed stand and a flange is on the center periphery to separate the fixed stand into front and rear; a conductive textile is convex installed inside the through-hole of the fixed stand, the conductive layer of the conductive textile is formed by vacuum sputtering (physics electroplating) or with no electrolytic plating (chemical plating); a plug is installed inside the through-hole of the fixed stand to stop the conductive textile. By this design, the conductive textile convex installed on the fixed stand formed by vacuum sputtering plating can be thinner in structure, faster in induction; elasticity offers higher accuracy, effectively for more convenience with no wastewater pollution, no environmental problem and no allergy reaction and has antibacterial effect..
09/11/14
20140256942

Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor


Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by h4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.. .
09/11/14
20140255434

Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity


The present invention relates to the preparation and use of variants of the group 5 allergen of the pooideae which are characterised by reduced ige reactivity compared with the known wild-type allergens and at the same time by substantially retained reactivity with t lymphocytes. These hypoallergenic allergen variants can be employed for the specific immunotherapy (hyposensitisation) of patients having grass pollen allergy or for the preventative immunotherapy of grass pollen allergies..
09/04/14
20140249048

Novel prostate kallikrein allergen


Methods for in vitro diagnosis of type i allergy comprises the steps of contacting an immunoglobulin-containing body fluid sample from a patient suspected of having type i allergy with a variant or fragment of the mature protein, amino acids 25-260, of the polypeptide of seq id no: 1, which variant or fragment shares epitopes for antibodies with the mature protein, amino acids 25-260, of the polypeptide of seq id no: 1; and detecting the presence, in the sample, of ige antibodies specifically binding to the variant or fragment. The presence of such ige antibodies specifically binding to the variant or fragment is indicative of a type i allergy in the patient..
08/28/14
20140243867

Surgically invasive pointed articles for skin penetration and methods for their preparation


A surgically invasive pointed article for skin penetration and its fabrication method are presented. The present invention comprises a protruding sharp end portion and a body portion, the protruding sharp end portion comprising at least one penetration tip that can be disabled after use.
08/28/14
20140242094

Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells


The present invention provides compositions and methods useful for promoting or reducing t-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (apc) activation.
08/28/14
20140241995

Micropatch for assessing chemical contact allergy


The micropatch of the present invention provides a reliable and effective system of elicitation necessary for the diagnostic identification of allergy cases whilst substantially reducing the chances of sensitising subjects, the present invention employs a micropatch.. .
08/21/14
20140234521

Low fat mayonnaise composition and producing the same


Provided are a low fat mayonnaise composition to which cellulose ether is applied, and a method of producing the same, in which the low fat mayonnaise composition includes 50 wt % or less of an emulsion with respect to the total weight of the composition, and cellulose ether and an excipient as a fat substitute. Therefore, with the mayonnaise composition, low fat mayonnaise which includes an oil and fat content of ½ or less may be produced from only a vegetable material having phase stability at various temperatures without using eggs which may lead to an allergy and may serve as a primary source of increasing cholesterol..
08/21/14
20140234423

Programming of cells for tolerogenic therapies


Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease..
08/21/14
20140234408

Beverage compositions and other formulations for treating allergies and methods for making the same


A composition for preventing and/or alleviating an allergy related condition and methods of making such compositions are disclosed herein. A composition in accordance with a particular embodiment can include honey having pollen derived from a known plant species and/or from a known geographic location.
08/14/14
20140228304

Combined allergy treatment and anti-drying compositions and related methods


Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy treatment composition or another anti-mucosal composition. In some embodiments and implementations, a composition may be provided comprising an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition.
08/07/14
20140220012

Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders


The present invention relates to a fusion proteins comprising regulatory t cell protein, vista (v-domain immunoglobulin suppressor of t cell activation (pd-l3) and an immunoglobulin protein (ig), preferably also containing a flexible linker intervening the vista and ig fc polypeptide. The invention also provides the use of vista polypeptides, multimeric vista polypeptides, vista-conjugates (e.g., vista-ig), and vista antagonists for the treatment of autoimmune disease, allergy, and inflammatory conditions, especially lupus, multiple sclerosis, psoriasis, psoriatic arthritis, multiple sclerosis, crohn's disease, inflammatory bowel disease and type 1 or type 2 diabetes..
08/07/14
20140219921

Immunomodulating compositions and methods


The disclosure provides compositions in the form of cells exhibiting the phenotype of a mesenchymal stem cell and uses of such cells in the preparation of medicament and the treatment of an allergic reaction in an asthmatic subject. Also provided are methods of inducing tolerance to an allergen in an asthmatic subject and methods of assessing a non-asthmatic subject for amenability to allergy treatment by administering mesenchymal stem cells..
07/31/14
20140213842

Methods and devices for treating primary headache


Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
07/31/14
20140213644

Formulations and methods for prevention and treatment of oral allergy syndrome


A method and formulation for the prevention and treatment for oral allergy syndrome (oas), also referred to as pollen-associated food allergy syndrome (pfas), is disclosed. The formulation significantly reduces or prevents symptoms related to oral allergy syndrome while having a superb safety record.
07/31/14
20140212492

Oral enzyme compositions for intestinal delivery


The present disclosure describes compositions for intestinal delivery of enzyme formulations and methods of treating health problems with these formulations. More specifically, the enzyme formulations include at least one histaminase and various methods of treatment of physical conditions, such as inflammation, allergy, histamine intolerance, and intestinal cancer..
07/10/14
20140194586

Method for treatment of synthetic rubber products, a system for treatment, the resulting rubber products, and use of a method to reduce type iv allergenicity of rubber products


The present invention relates to a method of reducing type iv rubber allergy of synthetic rubber latex products caused by chemical residues remaining after manufacture of the synthetic rubber products by reducing levels of chemical residues found for said products, said method comprising the steps of: subjecting said products to a wash in a strong alkaline solution to remove the chemical residues remaining after manufacture of the rubber latex products, and a system for reducing type iv allergenicity of synthetic rubber products caused by chemical residues remaining after manufacture of the synthetic rubber latex products by reducing residual levels of chemical residues found for said products, and a product, such as a glove, manufactured from synthetic rubber latex processed in accordance with the method and/or using the system. Further the invention relates to a use of a method of subjecting products to said wash and raising the temperature to at least 100c to remove the chemical residues remaining after manufacture of the synthetic rubber products..
07/10/14
20140193534

Epicatechin for alleviating symptoms of allergy


The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products..
07/10/14
20140193450

Peptide carrier fusion proteins as allergy vaccines


The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the n- and c-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.. .
07/10/14
20140193396

Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response


The invention provides immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit tlr-mediated signaling in response to a tlr ligand or tlr agonist.
07/03/14
20140187892

Device with integrated allergy testing


The disclosure provides an allergy detection system for use during catheterization. The allergy detection system is incorporated into specialized syringes, connectors for use with standard syringes, or can be an independent test module designed for the sole purpose of allergy detection.
07/03/14
20140186403

Peptide for vaccine


The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.. .
05/29/14
20140149114

Automatic decision support


Speech is transcribed to produce a transcript. At least some of the text in the transcript is encoded as data.
05/29/14
20140144555

Bio-co-cr-mo alloy with ion elution suppressed by structure control, and process for producing same


This invention provides a technique for rendering bio-toxicity such as allergy toxicity derived from ni trace impurity, i.e., nickel toxicity, which is unavoidably present in a bio-co—cr—mo alloy or an ni-free stainless steel alloy unharmful, characterized in that an element selected from the group consisting of the group 4, 5 and 13 elements of the periodic table, particularly an element selected from the group consisting of the group 4 elements of the periodic table, is added to the alloy composition. The additive element is preferably an element selected from the group consisting of zirconium and titanium, more preferably zirconium..
05/22/14
20140142321

Benzimidazole derivatives as pi3 kinase inhibitors


This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kα, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries.
05/22/14
20140141077

Composition for use in treating and preventing inflammation related disorder


The present invention is related to a use for treating and preventing inflammation related disorder of a composition containing a drug and hyaluronic acid (ha) or ha mixture, whereas the ha or the ha mixture as a delivery vehicle can be a formulation including at least two has having different average molecular weights. The composition has been demonstrated to be capable of reducing the therapeutic dose of a drug on the treatment and prevention of inflammation related disorders is acute inflammatory disease, chronic obstructed pulmonary disease, coeliac disease, conjunctivitis, otitis, allergic rhinitis, gingivitis, aphthous ulcer, bronchitis, gastroesophageal reflux disease (gerd), esophagitis, gastritis, enteritis, peptic ulcer, inflammatory bowel disease (ibd), crohn's disease, irritable bowel syndrome (ibs), intestinal inflammation or allergy, urethritis, cystitis, vaginitis, proctitis, eosinophilic gastroenteritis, or rheumatoid arthritis..
05/15/14
20140135361

Anti-allergy benzocycloheptathiophene derivatives


A method for treating an allergic reaction, or allergy diseases or disorders includes administering a therapeutically effective composition comprising a compound of formula i or a pharmaceutically acceptable salt, solvate or prodrug thereof and a pharmaceutically acceptable carrier, vehicle or excipient to a subject in need thereof.. .
05/15/14
20140135290

Macrocyclic prodrug compounds useful as therapeutics


The present invention includes macrocyclic prodrug compounds, pharmaceutical compositions containing them. The present invention also includes use of these compounds in the treatment of various diseases including an autoimmune disease, an inflammatory disease, a neurological or neurodegenerative disease, cancer, a cardiovascular disease, allergy, asthma, a hormone-related disease, and tumors or symptoms resulting from neurofibromatosis..
05/15/14
20140134739

Method of genetically altering and producing allergy free cats


A transgenic cat with a phenotype characterized by the substantial absence of the major cat allergen, fel d i. The phenotype is conferred in the transgenic cat by disrupting the coding sequence of the target gene with a specialized construct.
05/08/14
20140127289

Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity


In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.. .


Popular terms: [SEARCH]

Allergy topics: Autoimmune, Prophylactic, Ophthalmic, Autoimmune Disorder, Immune Disorder, Dermatitis, Staurosporin, Aspergillosis, Angioedema, Allergic Rhinitis, Food Allergy, Therapeutical, Bronchopulmonary, Staurosporine, Sudden Infant Death

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Allergy for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Allergy with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         





0.5292

3128

1 - 1 - 71